COPENHAGEN (Reuters) -Novo Nordisk said on Monday it would lower the U. price of its injectable Wegovy obesity drug and pledged to go "all in" on its upcoming oral weight-loss pill,​ as the firm races to claw back lost ground in the lucrative market.

Israel's haredi draft crisis intensifies as court ruling forces action, while political divisions and protests make it difficult to see a path forward. For months, the coalition’s showdown over haredi (ultra-Orthodox) enlistment unfolded like a drama with no final act – all buildup, no climax, and plenty of stalling.

This is great news for planetary defense.